The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

DENTSPLY International Inc

Nasdaq: XRAY
Last

(U.S.) $54.98

Today's change+0.46 +0.84%
Updated November 28 1:00 PM EST. Delayed by at least 15 minutes.
 

DENTSPLY International Inc

Nasdaq: XRAY
Last

(U.S.) $54.98

Today's change+0.46 +0.84%
Updated November 28 1:00 PM EST. Delayed by at least 15 minutes.

DENTSPLY International Inc Hits New 52-week High

DENTSPLY International Inc closed up Friday by (U.S.)$0.46 or 0.84% to (U.S.)$54.98 and setting a new 52-week high. Over the last five days, shares have gained 2.00% and 13.41% year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $54.91
  • Previous close(U.S.) $54.52
  • High(U.S.) $55.37
  • Low(U.S.) $54.50
  • Bid / Ask(U.S.) $51.08 / (U.S.) $58.89
  • YTD % change+13.41%
  • Volume315,955
  • Average volume (10-day)739,749
  • Average volume (1-month)941,060
  • Average volume (3-month)808,305
  • 52-week range(U.S.) $42.99 to (U.S.) $55.37
  • Beta1.32
  • Trailing P/E25.41×
  • P/E 1 year forward21.68×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.27
  • Dividend yield0.48%
  • Trailing EPS(U.S.) $2.16
Updated November 28 1:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.66%

Based on its net profit margin of 10.66%, DENTSPLY International Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.85%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2014Q2/2014Q1/2014Q4/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue708765730754
Total other revenue--------
Total revenue708765730754
Gross profit388424394398
Total cost of revenue320341336356
Total operating expense599638625656
Selling / general / administrative276296288292
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3118
Other operating expenses, total--------
Operating income11012710697
Interest income (expense), net non-operating-13-12-12-12
Gain (loss) on sale of assets--------
Other--------
Income before tax981169688
Income after tax76907375
Income tax, total21262213
Net income75907374
Total adjustments to net income--------
Net income before extra. items75907374
Minority interest000-2
Equity in affiliates-1001
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items75907374
Inc. avail. to common incl. extra. items75907374
Diluted net income75907374
Dilution adjustment--00--
Diluted weighted average shares144144144145
Diluted EPS excluding extraordinary itemsvalue per share0.520.620.500.51
Dividends per sharevalue per share0.070.070.060.06
Diluted normalized EPSvalue per share0.540.630.520.58